Registered Clinical Trials Investigating Ketamine for Psychiatric Disorders Read More > April 9, 2020
Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression Read More > February 1, 2020
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients Read More > January 13, 2020
Esketamine is approved in Europe for treating resistant major depressive disorder Read More > December 20, 2019
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Read More > December 14, 2019
High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans. Read More > November 1, 2019
